P-572 Phase I–II trial of TLK286 (telcyta), carboplatin (C), and paclitaxel(P) as first-line treatment for advanced non-small cell lung cancer (NSCLC)
- Resource Type
- Abstract
- Source
- In
Lung Cancer 2005 49 Supplement 2:S268-S269 - Subject
- Language
- ISSN
- 0169-5002